PureTech Scientific (Iron Path Capital) Acquires Glycolic Acid Business from The Chemours Company for $137 Million

June 1, 2023

PureTech Scientific, a company founded and backed by Iron Path Capital, agreed to acquire The Chemours Company's Glycolic Acid business for $137 million in cash. The transaction (a carve-out/divestiture) closed in August 2023 and creates a standalone platform focused on high‑purity alpha hydroxy acids for life sciences, specialty chemicals and personal care end markets.

Buyers
PureTech Scientific LLC, Iron Path Capital
Targets
Glycolic Acid business (The Chemours Company)
Sellers
The Chemours Company
Industry
Manufacturing
Location
West Virginia, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.